Excipients

Sheffied Tabletting System Disintequik MCC 25 is a co-processed excipient consisting of 75% Alpha monohydrate lactose and 25% Microcrystalline Cellulose (MCC). The processing results in a co-agglomeration compound of the two ingredients, spray dried lactose and MCC, preserving the identity of each component. Prior to processing, both ingredients meet all of the requirements as outlined in the current monographs of the EU, JP and NF. Disintequick MCC 25 reduces raw materials QC Testing, Manufacturing Steps and process validation. A Drug Master File is available. Added benefits include: reduction of blending issues, low dust generation, the avoidance of costly wet granulation processes, improved flowability and content uniformity during compression.

EFFER-SODA® SODIUM BICARBONATE, is a highly stable, surface modified sodium bicarbonate powder developed for use in pharmaceutical and nutraceutical applications.

Pharmaburst ® C1 a mixture of a disintegrant, a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols, a supplemental sugar alcohol, a supplemental flow agent, and a supplemental disintegrant.

Magaldrate (Al5Mg10(OH)31(SO4)2,xH20) is a basic aluminium and magnesium compound possessing a layer structure connected by water and sulphate bridges. It is crystalline by nature. This unique crystal lattice structure results in its high reactivity. The antacid effectiveness of magaldrate can be used to treat peptic ulcers because it neutralizes gastric acid very quickly while buffering the pH (keeping it between 5 and 6) even in the presence of proteins and pepsin.